Cas:28900-10-9 2-Chloro-6-methylnicotinonitrile manufacturer & supplier

We serve Chemical Name:2-Chloro-6-methylnicotinonitrile CAS:28900-10-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Chloro-6-methylnicotinonitrile

Chemical Name:2-Chloro-6-methylnicotinonitrile
CAS.NO:28900-10-9
Synonyms:F3250-0678;6-methyl-2-chloronicotinonitrile;2-Chloro-6-methyl-3-pyridinecarbonitrile;2-Chloro-6-methylnicotinonitrile;3-Pyridinecarbonitrile, 2-chloro-6-methyl-;2-Chloro-3-cyano-6-methylpyridine;2-Chloro-3-cyano-6-picoline;MFCD00082767
Molecular Formula:C7H5ClN2
Molecular Weight:152.581
HS Code:2933399090

Physical and Chemical Properties:
Melting point:114-116 °C(lit.)
Boiling point:278.2±35.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.555
PSA:36.68000
Exact Mass:152.014130
LogP:1.60

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3276
Packing Group:III


Contact us for information like F3250-0678 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00082767 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-methyl-2-chloronicotinonitrile Use and application,3-Pyridinecarbonitrile, 2-chloro-6-methyl- technical grade,usp/ep/jp grade.


Related News: But one clear concern among the CDC’s expert group this time around was the rapidly spreading Delta variant, first found in India. That mutated strain now accounts for over 80% of new U.S. infections that are sequenced, CDC data shows. 1,3-bis[(2-hydroxy-4-acetylamino-5-chlorophenylcarbamoyl)methyl]-3H-imidazol-1-ium chloride manufacturers EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. 9-Anthracenamine, N-(3-methylphenyl)-N-phenyl- suppliers “It’s truly an important scientific issue and important public health issue and FDA is actively exploring all regulatory options for providing access to additional doses of authorized vaccines in situations where data suggests the benefits would outweigh the risks,” Fink said. (2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoic acid vendor & factory.